Franklin Genomic Advancements Etf Buy Hold or Sell Recommendation
| HELX Etf | USD 29.86 0.33 1.12% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Franklin Genomic Advancements is 'Strong Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Franklin Genomic Advancements given historical horizon and risk tolerance towards Franklin Genomic. When Macroaxis issues a 'buy' or 'sell' recommendation for Franklin Genomic Advancements, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Franklin Genomic Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual funds such as Franklin and provide practical buy, sell, or hold recommendation based on investors' investing horizon and their risk tolerance towards Franklin Genomic Advancements. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Franklin |
Execute Franklin Genomic Buy or Sell Advice
The Franklin recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Franklin Genomic Advancements. Macroaxis does not own or have any residual interests in Franklin Genomic Advancements or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Franklin Genomic's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details |
Franklin Genomic Trading Alerts and Improvement Suggestions
| Franklin Genomic Adv generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Investment Analysis and Advice - Stock Traders Daily | |
| The fund created three year return of -16.0% | |
| Franklin Genomic Adv retains 98.96% of its assets under management (AUM) in equities |
Franklin Genomic Returns Distribution Density
The distribution of Franklin Genomic's historical returns is an attempt to chart the uncertainty of Franklin Genomic's future price movements. The chart of the probability distribution of Franklin Genomic daily returns describes the distribution of returns around its average expected value. We use Franklin Genomic Advancements price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Franklin Genomic returns is essential to provide solid investment advice for Franklin Genomic.
| Mean Return | -0.15 | Value At Risk | -1.97 | Potential Upside | 1.38 | Standard Deviation | 1.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Franklin Genomic historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Franklin Genomic Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Franklin Genomic or Franklin Templeton Investments sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Franklin Genomic's price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Franklin etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 1.00 | |
σ | Overall volatility | 1.20 | |
Ir | Information ratio | -0.24 |
Franklin Genomic Volatility Alert
Franklin Genomic Advancements exhibits very low volatility with skewness of -1.18 and kurtosis of 2.53. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Franklin Genomic's etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Franklin Genomic's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Franklin Genomic Fundamentals Vs Peers
Comparing Franklin Genomic's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Franklin Genomic's direct or indirect competition across all of the common fundamentals between Franklin Genomic and the related equities. This way, we can detect undervalued stocks with similar characteristics as Franklin Genomic or determine the etfs which would be an excellent addition to an existing portfolio. Peer analysis of Franklin Genomic's fundamental indicators could also be used in its relative valuation, which is a method of valuing Franklin Genomic by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Franklin Genomic to competition |
| Fundamentals | Franklin Genomic | Peer Average |
| Beta | 1.14 | |
| One Year Return | 7.60 % | (0.97) % |
| Three Year Return | (15.60) % | 3.23 % |
| Net Asset | 10.39 M | 2.29 B |
| Equity Positions Weight | 98.96 % | 52.82 % |
Note: Acquisition by Transier William L of 1843 shares of Franklin Genomic subject to Rule 16b-3 [view details]
Franklin Genomic Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Franklin . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Franklin Genomic Buy or Sell Advice
When is the right time to buy or sell Franklin Genomic Advancements? Buying financial instruments such as Franklin Etf isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Franklin Genomic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Copper Thematic Idea Now
Copper
Companies involved in production of copper. The Copper theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Copper Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Franklin Genomic Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of Franklin Genomic Adv is measured differently than its book value, which is the value of Franklin that is recorded on the company's balance sheet. Investors also form their own opinion of Franklin Genomic's value that differs from its market value or its book value, called intrinsic value, which is Franklin Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Franklin Genomic's market value can be influenced by many factors that don't directly affect Franklin Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Franklin Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Franklin Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.